AstraZeneca has out licensed worldwide rights to a Phase 3 ready novel chemical entity to Amani Therapeutics. The compound ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results